Key result
Transcatheter aortic valve implantation was successfully performed in a 74-year-old woman with critical aortic stenosis and porcelain aorta, resulting in symptom improvement from NYHA class III to I.
Case Report (n=1)
No
TAVI is a feasible and effective treatment for severe aortic stenosis in patients with prohibitively high surgical risk due to porcelain aorta and previous sternotomy.
May support TAVI feasibility in porcelain aorta; hypothesis-generating and should not yet change practice.
UNLABELLED: A 74-year-old woman who was diagnosed with right breast cancer at age 39 had been treated with mastectomy, and repeated cycles of chemotherapy and radiotherapy. She also had a history of coronary artery disease, wherein two coronary artery bypass grafts were performed 3 years ago. At that time, porcelain aorta was detected during surgery. In the year prior to admission, the patient presented with severe symptomatic critical aortic stenosis. Due to the prohibitively high surgical risk and need for aortic valve replacement, she underwent successful transcatheter aortic valve implantation with transfemoral implantation of a 29 mm Medtronic CoreValve prosthesis. The patient experienced a good result with reduction of the transaortic gradient and mild residual aortic regurgitation.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2015) conducted a case report in Critical aortic stenosis and porcelain aorta (n=1). Transcatheter aortic valve implantation (TAVI) was evaluated on Procedural success and symptom improvement. Transcatheter aortic valve implantation was successfully performed in a 74-year-old woman with critical aortic stenosis and porcelain aorta, resulting in symptom improvement from NYHA class III to I.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: